$139,753,636
CENTER FOR INNOVATIVE TRIALS IN CHILDREN AND ADULTS (TRIDENT)
Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.
What the model surfaced from this award
Funds Duke University's center conducting innovative clinical trials in children and adults through NIH cooperative agreement.
Establishes infrastructure for accelerated drug development and therapeutic testing across pediatric and adult populations, advancing precision medicine.
Drives demand for clinical trial management services, bioanalytical testing, regulatory consulting, and pharmaceutical development partnerships.
U.S. investment in domestic clinical trial capacity strengthens competitive advantage in drug development speed and regulatory approval pathways.
Generated by award_classification v2.0.0 via claude-haiku-4-5-20251001 on 2026-05-15. Cost: $0.002140.
- USAspending.gov — all awards for this UEI →
- SAM.gov entity registration →
- Award record ingested from usaspending. Source identifier ASST_NON_U24TR001608_075.
The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.